PCM Ai Opportunities Fund

Insider Reports History

Location
New York, NY
Signature
Puissance Life Science Opportunities Fund VI, By: Puissance Capital Fund (GP) LLC, its managing member, By: Theodore T. Wang, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PCM Ai Opportunities Fund:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. 10%+ Owner Common Stock 1,076,841 $111,776 $0.1038 07 Jun 2023 Direct

Insider Reports Filed by PCM Ai Opportunities Fund

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000176046023000006-puissance-life-science-opportunities-fund-vi-2023-06-07 Bellerophon Therapeutics, Inc. 07 Jun 2023 1 -$111,569 4 10%+ Owner 07 Jun 2023, 21:21
/report/000176046023000003-puissance-life-science-opportunities-fund-vi-2023-05-18 Bellerophon Therapeutics, Inc. 18 May 2023 1 -$5,297,600 4 10%+ Owner 19 May 2023, 20:55
/report/000176046021000004-puissance-life-science-opportunities-fund-vi-2021-06-07 Bellerophon Therapeutics, Inc. 07 Jun 2021 1 +$32,756 4 10%+ Owner 08 Jun 2021, 12:37